{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:59:17Z","timestamp":1776833957660,"version":"3.51.2"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.clinbiochem.2021.12.001","type":"journal-article","created":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T16:08:49Z","timestamp":1638720529000},"page":"4-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A focused review on Lyme disease diagnostic testing: An update on serology algorithms, current ordering practices, and practical considerations for laboratory implementation of a new testing algorithm"],"prefix":"10.1016","volume":"117","author":[{"given":"Stacy M.","family":"Kenyon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siaw Li","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinbiochem.2021.12.001_b0005","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jme\/tjv237","article-title":"County-Scale Distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the Continental United States","volume":"53","author":"Eisen","year":"2016","journal-title":"J. Med. Entomol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.12.001_b0010","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010\u20132018","volume":"27","author":"Kugeler","year":"2021","journal-title":"Emerg. Infect. Dis."},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.12.001_b0015","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3201\/eid2108.141878","article-title":"Geographic Distribution and Expansion of Human Lyme Disease","volume":"21","author":"Kugeler","year":"2015","journal-title":"United States. Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.12.001_b0020","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00018-19","article-title":"Laboratory Diagnosis of Lyme Borreliosis","volume":"34","author":"Branda","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.12.001_b0025","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cll.2015.08.001","article-title":"Lyme Disease Diagnosis: Serology","volume":"35","author":"Schriefer","year":"2015","journal-title":"Clin. Lab. Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.12.001_b0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/JCM.40.2.319-324.2002","article-title":"Laboratory testing for Lyme disease: possibilities and practicalities","volume":"40","author":"Reed","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2021.12.001_b0035","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1128\/JCM.43.10.5080-5084.2005","article-title":"Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease","volume":"43","author":"Coulter","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.12.001_b0040","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/323424","article-title":"Yield of large-volume blood cultures in patients with early Lyme disease","volume":"184","author":"Wormser","year":"2001","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.12.001_b0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/CMR.10.1.185","article-title":"PCR in laboratory diagnosis of human Borrelia burgdorferi infections","volume":"10","author":"Schmidt","year":"1997","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.12.001_b0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/infdis\/174.3.623","article-title":"Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis","volume":"174","author":"Nocton","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.12.001_b0055","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1128\/CMR.18.3.484-509.2005","article-title":"Diagnosis of lyme borreliosis","volume":"18","author":"Aguero-Rosenfeld","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.12.001_b0060","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.diagmicrobio.2008.08.016","article-title":"Percent positive rate of Lyme real-time polymerase chain reaction in blood, cerebrospinal fluid, synovial fluid, and tissue","volume":"62","author":"Babady","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.clinbiochem.2021.12.001_b0065","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.3390\/ijms15034284","article-title":"Detection of borreliae in archived sera from patients with clinically suspect Lyme disease","volume":"15","author":"Lee","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.12.001_b0070","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01406-18","article-title":"Limitations and Confusing Aspects of Diagnostic Testing for Neurologic Lyme Disease in the United States","volume":"57","author":"Theel","year":"2019","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.12.001_b0075","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/clind\/15.5.788","article-title":"Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease","volume":"15","author":"Feder","year":"1992","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.clinbiochem.2021.12.001_b0080","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/JCM.00874-16","article-title":"Lyme Borreliosis Serology: Performance of Several Commonly Used Laboratory Diagnostic Tests and a Large Resource Panel of Well-Characterized Patient Samples","volume":"54","author":"Molins","year":"2016","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0085","unstructured":"Centers for Disease C, Prevention: Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 1995, 44(31):590-591."},{"issue":"32","key":"10.1016\/j.clinbiochem.2021.12.001_b0090","doi-asserted-by":"crossref","first-page":"703","DOI":"10.15585\/mmwr.mm6832a4","article-title":"Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease","volume":"68","author":"Mead","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0095","unstructured":"BioRad Bioplex2200. Lyme Total [package insert]. 01-665-0563A, 2019-03. English. Bio-Rad Laboratories, Inc."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0100","unstructured":"FDA Premarket Notification: Gold Standard Diagnostics Borrelia burgdorferi IgG\/IgM ELISA Test Kit. 510(k) Substantial Equivalence Determination Decision Summary. K180264. 2018."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0105","unstructured":"LIAISON\u00ae Lyme Total Antibody Plus [package insert]. US 54404, 2021-03. English. DiaSorin Inc."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0110","unstructured":"VIDAS\u00ae Lyme IgG II (LYG) [package insert]. 9303465 A, 2014-06. English. bioM\u00e9rieux SA."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0115","unstructured":"VIDAS\u00ae Lyme IgM II (LYM) [package insert]. 9303464 A, 2014-06. English. bioM\u00e9rieux SA."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0120","unstructured":"ZEUS ELISA Borrelia VlsE1\/pepC10 IgG\/IgM Test System [package insert]. 2019-08. English. Zeus Scientific, Inc."},{"issue":"12","key":"10.1016\/j.clinbiochem.2021.12.001_b0125","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1469-0691.2011.03749.x","article-title":"High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice","volume":"18","author":"Seriburi","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.12.001_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14737159.2015.989837","article-title":"Lyme disease: diagnostic issues and controversies","volume":"15","author":"Aguero-Rosenfeld","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"issue":"6","key":"10.1016\/j.clinbiochem.2021.12.001_b0135","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/cid\/cir464","article-title":"Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay","volume":"53","author":"Branda","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.12.001_b0140","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/cid\/cix043","article-title":"Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease","volume":"64","author":"Branda","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.12.001_b0145","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01943-17","article-title":"Evaluation of Modified Two-Tiered Testing Algorithms for Lyme Disease Laboratory Diagnosis Using Well-Characterized Serum Samples","volume":"56","author":"Pegalajar-Jurado","year":"2018","journal-title":"J. Clin. Microbiol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2021.12.001_b0150","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00547-19","article-title":"Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children","volume":"57","author":"Lipsett","year":"2019","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.12.001_b0155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1086\/589242","article-title":"Prospective study of serologic tests for lyme disease","volume":"47","author":"Steere","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0160","unstructured":"APHL: Suggested Reporting Language, Interpretation and Guidance Regarding Lyme Disease Serologic Test Results. In., 2021."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.12.001_b0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.14745\/ccdr.v46i05a05","article-title":"the Canadian context","volume":"46","author":"Hatchette","year":"2020","journal-title":"Can. Commun. Dis. Rep."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0170","unstructured":"FDA Premarket Notification: Gold Standard Diagnostics Borrelia burgdorferi IgG ELISA Test Kit. 510(k) Substantial Equivalence Determination Decision Summary. K203296, 2021."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0175","unstructured":"FDA Premarket Notification: Gold Standard Diagnostics Borrelia burgdorferi IgM ELISA Test Kit. 510(k) Substantial Equivalence Determination Decision Summary. K203295, 2021."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0180","unstructured":"LIAISON\u00ae Lyme IgG [package insert]. US 54403, 2021-03. English. DiaSorin, Inc."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0185","unstructured":"LIAISON\u00ae Lyme IgM [package insert]. US 54402, 2021-03. English. DiaSorin, Inc."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0190","unstructured":"ZEUS ELISA Borrelia burgdorferi IgG Test System [package insert]. 2020-01. English. Zeus Scientific, Inc."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0195","unstructured":"ZEUS ELISA Borrelia burgdorferi IgM Test System [package insert]. 2020-01. English. Zeus Scientific, Inc."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0200","doi-asserted-by":"crossref","unstructured":"PM, Lantos, J, Rumbaugh, LK, Bockenstedt, YT, Falck-Ytter, ME, Aguero-Rosenfeld, PG, Auwaerter, K, Baldwin, RR, Bannuru, KK, Belani, WR Bowie et al: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease. Clin Infect Dis 2021, 72(1):1-8.","DOI":"10.1093\/cid\/ciaa1215"},{"issue":"9","key":"10.1016\/j.clinbiochem.2021.12.001_b0205","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00006454-199609000-00003","article-title":"Misdiagnosis of Lyme disease: when not to order serologic tests","volume":"15","author":"Seltzer","year":"1996","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"5","key":"10.1016\/j.clinbiochem.2021.12.001_b0210","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/cid\/ciu397","article-title":"Lyme disease testing by large commercial laboratories in the United States","volume":"59","author":"Hinckley","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0215","doi-asserted-by":"crossref","unstructured":"RM Boyce, C Speight, JT Lin, CE Farel, Errors in Diagnostic Test Use and Interpretation Contribute to the High Number of Lyme Disease Referrals in a Low-Incidence State. Open Forum Infect Dis 2020, 7(1):ofaa009.","DOI":"10.1093\/ofid\/ofaa009"},{"issue":"7","key":"10.1016\/j.clinbiochem.2021.12.001_b0220","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/archderm.142.7.862","article-title":"Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients","volume":"142","author":"Glatz","year":"2006","journal-title":"Arch. Dermatol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2021.12.001_b0225","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/521256","article-title":"Reinfection in patients with Lyme disease","volume":"45","author":"Nadelman","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.clinbiochem.2021.12.001_b0230","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199401273300401","article-title":"Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis","volume":"330","author":"Nocton","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0235","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fmed.2020.00265","article-title":"A Practical Approach to the Diagnosis of Lyme Borreliosis: From Clinical Heterogeneity to Laboratory Methods","volume":"7","author":"Trevisan","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clinbiochem.2021.12.001_b0240","unstructured":"Sofia 2 Lyme FIA [package insert]. 1334700EN00, 2018-08. English. Quidel Corporation."},{"issue":"12","key":"10.1016\/j.clinbiochem.2021.12.001_b0245","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01142-19","article-title":"A Multiplexed Serologic Test for Diagnosis of Lyme Disease for Point-of-Care Use","volume":"57","author":"Arumugam","year":"2019","journal-title":"J. Clin. Microbiol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2021.12.001_b0250","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01836-20","article-title":"Serum Epitope Repertoire Analysis Enables Early Detection of Lyme Disease with Improved Sensitivity in an Expandable Multiplex Format","volume":"59","author":"Reifert","year":"2021","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2021.12.001_b0255","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75036-2","article-title":"An ultra-high-density protein microarray for high throughput single-tier serological detection of Lyme disease","volume":"10","author":"Jayaraman","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021003180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912021003180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:00:07Z","timestamp":1757865607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912021003180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":51,"alternative-id":["S0009912021003180"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.12.001","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A focused review on Lyme disease diagnostic testing: An update on serology algorithms, current ordering practices, and practical considerations for laboratory implementation of a new testing algorithm","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2021.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}